LISATA THERAPEUTICS, INC. Proceeds from Notes Payable
LISATA THERAPEUTICS, INC. (LSTA) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2019-03-14
- LISATA THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2018-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2018-06-30 was $0.00.
- LISATA THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. proceeds from notes payable for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- LISATA THERAPEUTICS, INC. proceeds from notes payable for fiscal 2017 was $401.00K, a 50.09% decline from fiscal 2016.
- LISATA THERAPEUTICS, INC. proceeds from notes payable for fiscal 2016 was $803.50K, a 26.11% decline from fiscal 2015.
- LISATA THERAPEUTICS, INC. proceeds from notes payable for fiscal 2015 was $1.09M, a 40.50% decline from fiscal 2014.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 6 month as first filed | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 9 month as first filed | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $0.00 derived: sum of 3 quarters · filed 2019-03-14 | $0.00 10-K · filed 2019-03-14 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | $2.00 derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | $2.00 derived: sum of 3 quarters · filed 2019-03-14 | $2.00 derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | $2.00 derived: sum of 2 quarters · filed 2019-03-14 | $2.00 derived: sum of 3 quarters · filed 2019-03-14 | $2.00 derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2017-12-31 | $2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $2.00 derived: sum of 2 quarters · filed 2019-03-14 | $2.00 derived: sum of 3 quarters · filed 2019-03-14 | $401.00K 10-K · filed 2019-03-14 | $401.00K 10-K · filed 2018-03-22 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $401.00K 10-Q · filed 2018-11-08 | $835.88K derived: sum of 4 quarters · filed 2018-11-08 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $401.00K 10-Q · filed 2018-08-09 | $835.88K derived: sum of 3 quarters · filed 2018-08-09 | $835.88K derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $401.00K 10-Q · filed 2018-05-10 | $835.88K derived: sum of 2 quarters · filed 2018-05-10 | $835.88K derived: sum of 3 quarters · filed 2018-05-10 | $835.88K derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $434.88K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $434.88K derived: sum of 2 quarters · filed 2018-03-22 | $434.88K derived: sum of 3 quarters · filed 2018-03-22 | $803.50K 10-K · filed 2018-03-22 | $979.58K 10-K · filed 2017-03-17 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $368.62K 10-Q · filed 2017-11-09 | $368.62K derived: sum of 4 quarters · filed 2017-11-09 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $368.62K 10-Q · filed 2017-08-10 | $368.62K derived: sum of 3 quarters · filed 2017-08-10 | $366.37K derived: sum of 4 quarters · filed 2017-08-10 | |||
| 2016-03-31 | $368.62K 10-Q · filed 2017-05-15 | $368.62K derived: sum of 2 quarters · filed 2017-05-15 | $366.37K derived: sum of 3 quarters · filed 2017-05-15 | $1.12M derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$2.25K derived: sum of 2 quarters · filed 2017-03-17 | $747.09K derived: sum of 3 quarters · filed 2017-03-17 | $1.09M 10-K · filed 2017-03-17 | |||
| 2015-09-30 | -$2.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $747.09K derived: sum of 2 quarters · filed 2016-11-07 | $1.09M 10-Q · filed 2016-11-07 | $1.14M derived: sum of 4 quarters · filed 2016-11-07 | |||
| 2015-06-30 | $749.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.09M 10-Q · filed 2016-08-09 | $1.14M derived: sum of 3 quarters · filed 2016-08-09 | $1.58M derived: sum of 4 quarters · filed 2016-08-09 | |||
| 2015-03-31 | $340.27K 10-Q · filed 2016-05-05 | $390.52K derived: sum of 2 quarters · filed 2016-05-05 | $826.70K derived: sum of 3 quarters · filed 2016-05-05 | $1.21M derived: sum of 4 quarters · filed 2016-05-05 | |||
| 2014-12-31 | $50.25K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $486.43K derived: sum of 2 quarters · filed 2016-03-15 | $869.40K derived: sum of 3 quarters · filed 2016-03-15 | $1.83M 10-K · filed 2016-03-15 | |||
| 2014-09-30 | $436.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $819.15K derived: sum of 2 quarters · filed 2015-11-05 | $1.78M 10-Q · filed 2015-11-05 | $2.11M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | $382.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.34M 10-Q · filed 2015-08-06 | $1.67M derived: sum of 3 quarters · filed 2016-03-15 | $2.16M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | $958.01K 10-Q · filed 2015-05-06 | $1.29M derived: sum of 2 quarters · filed 2016-03-15 | $1.78M derived: sum of 3 quarters · filed 2016-03-15 | $2.00M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2013-12-31 | $331.61K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $820.13K derived: sum of 2 quarters · filed 2016-03-15 | $1.04M derived: sum of 3 quarters · filed 2016-03-15 | $1.04M 10-K · filed 2016-03-15 | |||
| 2013-09-30 | $488.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $709.74K derived: sum of 2 quarters · filed 2014-10-30 | $709.74K 10-Q · filed 2014-10-30 | $1.15M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-06-30 | $221.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $221.22K 10-Q · filed 2014-08-07 | $664.29K derived: sum of 3 quarters · filed 2015-03-02 | $664.29K derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-08 | $443.07K derived: sum of 2 quarters · filed 2015-03-02 | $443.07K derived: sum of 3 quarters · filed 2015-03-02 | $443.07K derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | $443.07K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $443.07K derived: sum of 2 quarters · filed 2015-03-02 | $443.07K derived: sum of 3 quarters · filed 2015-03-02 | $666.50K 10-K · filed 2015-03-02 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $223.43K 10-Q · filed 2013-11-07 | $223.43K derived: sum of 4 quarters · filed 2013-11-07 | |||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $223.43K 10-Q · filed 2013-08-08 | $223.43K derived: sum of 3 quarters · filed 2013-08-08 | $223.43K derived: sum of 4 quarters · filed 2013-08-08 | |||
| 2012-03-31 | $223.43K 10-Q · filed 2013-05-09 | $223.43K derived: sum of 2 quarters · filed 2013-05-09 | $223.43K derived: sum of 3 quarters · filed 2013-05-09 | -$6.88M derived: sum of 4 quarters · filed 2013-05-09 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $0.00 derived: sum of 2 quarters · filed 2013-03-11 | -$7.10M derived: sum of 3 quarters · filed 2013-03-11 | $149.77K 10-K · filed 2013-03-11 | $10.95M 10-K · filed 2012-03-20 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$7.10M derived: sum of 2 quarters · filed 2012-11-13 | $149.77K 10-Q · filed 2012-11-13 | $10.95M 10-Q · filed 2011-11-10 | -$12.68M derived: sum of 4 quarters · filed 2012-11-13 | ||
| 2011-06-30 | -$7.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $149.77K 10-Q · filed 2012-08-14 | $10.95M 10-Q · filed 2011-08-12 | -$12.68M derived: sum of 3 quarters · filed 2012-08-15 | -$10.47M derived: sum of 4 quarters · filed 2012-08-15 | ||
| 2011-03-31 | $7.25M 10-Q · filed 2012-05-11 | -$5.58M derived: sum of 2 quarters · filed 2012-08-15 | -$3.37M derived: sum of 3 quarters · filed 2012-08-15 | ||||
| 2010-12-31 | -$12.83M derived: 8-K 12 month − 10-Q 9 month · filed 2012-08-15 | -$10.62M derived: sum of 2 quarters · filed 2012-08-15 | $431.52K 8-K · filed 2012-08-15 | $20.51M 10-K · filed 2012-03-20 | |||
| 2010-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $13.26M 10-Q · filed 2011-11-10 | |||||
| 2010-06-30 | $11.05M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |